TapewireFind a company

person · Reporting owner

McCracken Colin

Disclosed activity across 1 company

Tapewire entity
130033
SEC CIK
0001775380

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
STANDARD BIOTOOLS INC.FLDM · Entity 6116Chief Commercial OfficerFebruary 22, 2022February 24, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

STANDARD BIOTOOLS INC.

Report date February 22, 2022 · Filed February 24, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect65,103 Ending reported balance After 2022-02-22 transaction · row 4
4 source rows · reconciled sequence

Row 1 · 2022-02-22 · Exercise / conversion · Acquired 1,531 · Balance 63,854

Row 2 · 2022-02-22 · Exercise / conversion · Acquired 2,391 · Balance 66,245

Row 3 · 2022-02-22 · Exercise / conversion · Acquired 2,598 · Balance 68,843

Row 4 · 2022-02-22 · Tax withholding · Disposed 3,740 · Balance 65,103

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect7,657 Reported balance After 2022-02-22 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2022-02-22 · Exercise / conversion · Disposed 1,531 · Balance 7,657

F1: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect19,126 Reported balance After 2022-02-22 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2022-02-22 · Exercise / conversion · Disposed 2,391 · Balance 19,126

F1: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F3: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect12,989 Reported balance After 2022-02-22 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2022-02-22 · Exercise / conversion · Disposed 2,598 · Balance 12,989

F1: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F4: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F3: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

F4: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
February 22, 2022 Filed Feb 24, 2022 22:18 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 2,598 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000017 · wf-form4_164574106408439.xml · derivative · entry 7

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,989

Underlying: Common Stock · 2,598 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F4 · derivative.exercise_date: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F4 · derivative.expiration_date: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
February 22, 2022 Filed Feb 24, 2022 22:18 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 2,391 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000017 · wf-form4_164574106408439.xml · derivative · entry 6

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,126

Underlying: Common Stock · 2,391 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F3 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

F3 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
February 22, 2022 Filed Feb 24, 2022 22:18 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 1,531 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000017 · wf-form4_164574106408439.xml · derivative · entry 5

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,657

Underlying: Common Stock · 1,531 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2 · derivative.exercise_date: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F2 · derivative.expiration_date: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
February 22, 2022 Filed Feb 24, 2022 22:18 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Tax withholdingCommon Stock 3,740 $3.62 $13,538.80
Disclosure

SEC source: 0001162194-22-000017 · wf-form4_164574106408439.xml · nonDerivative · entry 4

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,103

Read SEC document
February 22, 2022 Filed Feb 24, 2022 22:18 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 2,598 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000017 · wf-form4_164574106408439.xml · nonDerivative · entry 3

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,843

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 22, 2022 Filed Feb 24, 2022 22:18 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 2,391 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000017 · wf-form4_164574106408439.xml · nonDerivative · entry 2

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,245

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 22, 2022 Filed Feb 24, 2022 22:18 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 1,531 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000017 · wf-form4_164574106408439.xml · nonDerivative · entry 1

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,854

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 23, 2022 Filed Jan 26, 2022 00:37 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 GrantRestricted Stock Units · Derivative 50,000 $0.00 $0.00
Disclosure

SEC source: 0001162194-22-000008 · wf-form4_164315745888368.xml · derivative · entry 1

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2 · derivative.exercise_date: The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without "cause."

F2 · derivative.expiration_date: The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without "cause."

Read SEC document
November 20, 2021 Filed Nov 24, 2021 23:45 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 2,390 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000097 · wf-form4_163779753920021.xml · derivative · entry 7

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,517

Underlying: Common Stock · 2,390 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F4 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

F4 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
November 20, 2021 Filed Nov 24, 2021 23:45 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 1,531 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000097 · wf-form4_163779753920021.xml · derivative · entry 6

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,188

Underlying: Common Stock · 1,531 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F3 · derivative.exercise_date: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F3 · derivative.expiration_date: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
November 20, 2021 Filed Nov 24, 2021 23:45 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 2,598 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000097 · wf-form4_163779753920021.xml · derivative · entry 5

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,587

Underlying: Common Stock · 2,598 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2 · derivative.exercise_date: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F2 · derivative.expiration_date: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
November 20, 2021 Filed Nov 24, 2021 23:45 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Tax withholdingCommon Stock 3,530 $4.49 $15,849.70
Disclosure

SEC source: 0001162194-21-000097 · wf-form4_163779753920021.xml · nonDerivative · entry 4

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,323

Read SEC document
November 20, 2021 Filed Nov 24, 2021 23:45 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 2,390 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000097 · wf-form4_163779753920021.xml · nonDerivative · entry 3

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,853

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 20, 2021 Filed Nov 24, 2021 23:45 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 1,531 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000097 · wf-form4_163779753920021.xml · nonDerivative · entry 2

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,463

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 20, 2021 Filed Nov 24, 2021 23:45 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 2,598 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000097 · wf-form4_163779753920021.xml · nonDerivative · entry 1

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,932

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 23:11 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 2,391 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000082 · wf-form4_162984664031679.xml · derivative · entry 7

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,907

Underlying: Common Stock · 2,391 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F4 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

F4 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 23:11 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 1,531 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000082 · wf-form4_162984664031679.xml · derivative · entry 6

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,719

Underlying: Common Stock · 1,531 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F3 · derivative.exercise_date: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F3 · derivative.expiration_date: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 23:11 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 2,597 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000082 · wf-form4_162984664031679.xml · derivative · entry 5

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,185

Underlying: Common Stock · 2,597 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2 · derivative.exercise_date: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F2 · derivative.expiration_date: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 23:11 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Tax withholdingCommon Stock 3,523 $6.53 $23,005.19
Disclosure

SEC source: 0001162194-21-000082 · wf-form4_162984664031679.xml · nonDerivative · entry 4

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,334

Read SEC document
August 20, 2021 Filed Aug 24, 2021 23:11 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 2,391 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000082 · wf-form4_162984664031679.xml · nonDerivative · entry 3

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,857

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 23:11 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 1,531 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000082 · wf-form4_162984664031679.xml · nonDerivative · entry 2

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,466

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 23:11 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 2,597 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000082 · wf-form4_162984664031679.xml · nonDerivative · entry 1

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,935

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:08 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 60,000 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000042 · wf-form4_162188687090616.xml · derivative · entry 9

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F5 · derivative.exercise_date: On May 23, 2020, the Reporting Person was granted 120,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023.

F5 · derivative.expiration_date: On May 23, 2020, the Reporting Person was granted 120,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:08 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 2,390 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000042 · wf-form4_162188687090616.xml · derivative · entry 8

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,298

Underlying: Common Stock · 2,390 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F4 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

F4 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:08 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 1,532 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000042 · wf-form4_162188687090616.xml · derivative · entry 7

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,250

Underlying: Common Stock · 1,532 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F3 · derivative.exercise_date: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F3 · derivative.expiration_date: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:08 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 2,598 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000042 · wf-form4_162188687090616.xml · derivative · entry 6

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,782

Underlying: Common Stock · 2,598 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2 · derivative.exercise_date: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F2 · derivative.expiration_date: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:08 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Tax withholdingCommon Stock 36,087 $5.52 $199,200.24
Disclosure

SEC source: 0001162194-21-000042 · wf-form4_162188687090616.xml · nonDerivative · entry 5

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,338

Read SEC document
May 20, 2021 Filed May 24, 2021 20:08 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 60,000 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000042 · wf-form4_162188687090616.xml · nonDerivative · entry 4

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,425

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:08 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 2,390 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000042 · wf-form4_162188687090616.xml · nonDerivative · entry 3

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,425

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:08 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 1,532 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000042 · wf-form4_162188687090616.xml · nonDerivative · entry 2

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,035

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:08 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 2,598 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000042 · wf-form4_162188687090616.xml · nonDerivative · entry 1

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,503

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 20, 2021 Filed Apr 22, 2021 22:31 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 GrantRestricted Stock Units · Derivative 65,792 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000032 · wf-form4_161913069571662.xml · derivative · entry 1

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,792

Underlying: Common Stock · 65,792 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2 · derivative.exercise_date: Restricted Stock Units vest as to 1/4 of the underlying shares on May 20, 2022, and as to an additional 1/16th of the total number of shares each quarter thereafter.

F2 · derivative.expiration_date: Restricted Stock Units vest as to 1/4 of the underlying shares on May 20, 2022, and as to an additional 1/16th of the total number of shares each quarter thereafter.

Read SEC document
February 20, 2021 Filed Feb 24, 2021 02:57 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 9,562 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000007 · wf-form4_161413543384058.xml · derivative · entry 7

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,688

Underlying: Common Stock · 9,562 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F4 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

F4 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
February 20, 2021 Filed Feb 24, 2021 02:57 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 1,531 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000007 · wf-form4_161413543384058.xml · derivative · entry 6

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,782

Underlying: Common Stock · 1,531 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F3 · derivative.exercise_date: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F3 · derivative.expiration_date: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
February 20, 2021 Filed Feb 24, 2021 02:57 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 2,598 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000007 · wf-form4_161413543384058.xml · derivative · entry 5

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,380

Underlying: Common Stock · 2,598 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2 · derivative.exercise_date: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F2 · derivative.expiration_date: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
February 20, 2021 Filed Feb 24, 2021 02:57 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Tax withholdingCommon Stock 7,872 $6.12 $48,176.64
Disclosure

SEC source: 0001162194-21-000007 · wf-form4_161413543384058.xml · nonDerivative · entry 4

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,905

Read SEC document
February 20, 2021 Filed Feb 24, 2021 02:57 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 9,562 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000007 · wf-form4_161413543384058.xml · nonDerivative · entry 3

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,777

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 20, 2021 Filed Feb 24, 2021 02:57 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 1,531 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000007 · wf-form4_161413543384058.xml · nonDerivative · entry 2

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,215

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 20, 2021 Filed Feb 24, 2021 02:57 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 2,598 $0.00 $0.00
Disclosure

SEC source: 0001162194-21-000007 · wf-form4_161413543384058.xml · nonDerivative · entry 1

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 20, 2020 Filed Nov 24, 2020 22:21 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 1,531 $0.00 $0.00
Disclosure

SEC source: 0001162194-20-000112 · wf-form4_160625649736161.xml · derivative · entry 5

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,313

Underlying: Common Stock · 1,531 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F3 · derivative.exercise_date: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F3 · derivative.expiration_date: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
November 20, 2020 Filed Nov 24, 2020 22:21 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 2,598 $0.00 $0.00
Disclosure

SEC source: 0001162194-20-000112 · wf-form4_160625649736161.xml · derivative · entry 4

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,978

Underlying: Common Stock · 2,598 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2 · derivative.exercise_date: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F2 · derivative.expiration_date: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
November 20, 2020 Filed Nov 24, 2020 22:21 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Tax withholdingCommon Stock 1,699 $6.28 $10,669.72
Disclosure

SEC source: 0001162194-20-000112 · wf-form4_160625649736161.xml · nonDerivative · entry 3

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,086

Read SEC document
November 20, 2020 Filed Nov 24, 2020 22:21 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 1,531 $0.00 $0.00
Disclosure

SEC source: 0001162194-20-000112 · wf-form4_160625649736161.xml · nonDerivative · entry 2

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,785

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 20, 2020 Filed Nov 24, 2020 22:21 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 2,598 $0.00 $0.00
Disclosure

SEC source: 0001162194-20-000112 · wf-form4_160625649736161.xml · nonDerivative · entry 1

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,254

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 20, 2020 Filed Aug 24, 2020 23:20 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 1,531 $0.00 $0.00
Disclosure

SEC source: 0001162194-20-000099 · wf-form4_159831114580372.xml · derivative · entry 5

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,844

Underlying: Common Stock · 1,531 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F3 · derivative.exercise_date: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F3 · derivative.expiration_date: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
August 20, 2020 Filed Aug 24, 2020 23:20 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionRestricted Stock Units · Derivative 2,597 $0.00 $0.00
Disclosure

SEC source: 0001162194-20-000099 · wf-form4_159831114580372.xml · derivative · entry 4

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,576

Underlying: Common Stock · 2,597 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2 · derivative.exercise_date: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F2 · derivative.expiration_date: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

Read SEC document
August 20, 2020 Filed Aug 24, 2020 23:20 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Tax withholdingCommon Stock 1,698 $7.91 $13,431.18
Disclosure

SEC source: 0001162194-20-000099 · wf-form4_159831114580372.xml · nonDerivative · entry 3

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,656

Read SEC document
August 20, 2020 Filed Aug 24, 2020 23:20 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 1,531 $0.00 $0.00
Disclosure

SEC source: 0001162194-20-000099 · wf-form4_159831114580372.xml · nonDerivative · entry 2

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,354

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 20, 2020 Filed Aug 24, 2020 23:20 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 Exercise / conversionCommon Stock 2,597 $0.00 $0.00
Disclosure

SEC source: 0001162194-20-000099 · wf-form4_159831114580372.xml · nonDerivative · entry 1

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,823

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 23, 2020 Filed May 26, 2020 13:32 UTC STANDARD BIOTOOLS INC. FLDM · Entity 6116 GrantRestricted Stock Units · Derivative 120,000 $0.00 $0.00
Disclosure

SEC source: 0001162194-20-000063 · wf-form4_159049992724775.xml · derivative · entry 1

McCracken Colin · CIK 0001775380 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2 · derivative.exercise_date: Restricted Stock Units vest over three years, with 1/2 of the total number of shares vesting on May 20, 2021 and 1/4 of the total number of shares vesting on each of May 20, 2022 and May 20, 2023.

F2 · derivative.expiration_date: Restricted Stock Units vest over three years, with 1/2 of the total number of shares vesting on May 20, 2021 and 1/4 of the total number of shares vesting on each of May 20, 2022 and May 20, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.